The Schall Law Firm has initiated a securities fraud class action lawsuit against Picard Medical, Inc. (PMI), targeting investors who purchased company securities during a specific nine-week window from September 2, 2025 through October 31, 2025. According to the complaint, the company allegedly issued false and misleading statements to the market during this period.
The lawsuit alleges that PMI engaged in a coordinated scheme to artificially inflate its share price, which enabled company insiders to sell their holdings at artificially elevated valuations. This practice, commonly referred to as a "pump and dump" scheme, is designed to deceive investors about the true financial condition and prospects of the company. The timing of insider sales coinciding with the alleged misstatements forms a key component of the fraud allegations.
Investors who acquired PMI securities between the specified dates are being solicited to participate in the class action proceeding. The firm is accepting new plaintiffs to serve as lead representatives in the litigation. Class action lawsuits of this nature typically seek monetary damages for affected shareholders, with recovery amounts dependent on settlement negotiations or adverse judgment outcomes.